Considerations for systemic treatment of psoriasis in obese patients

P Gisondi, M Del Giglio, G Girolomoni - American journal of clinical …, 2016 - Springer
Psoriasis is an immune-mediated inflammatory skin disease frequently associated with
metabolic disorders, including diabetes, dyslipidaemia and metabolic syndrome. Moreover …
被引用次数：54 相关文章

Considerations for Systemic Treatment of Psoriasis in Obese Patients

P Gisondi, M DEL GIGLIO, G Girolomoni - AMERICAN JOURNAL OF …, 2016 - iris.univr.it
Psoriasis is an immune-mediated inflammatory skin disease frequently associated with
metabolic disorders, including diabetes, dyslipidaemia and metabolic syndrome. Moreover …

Considerations for Systemic Treatment of Psoriasis in Obese Patients.

P Gisondi, M Del Giglio, G Girolomoni - American Journal of Clinical …, 2016 - europepmc.org
Psoriasis is an immune-mediated inflammatory skin disease frequently associated with
metabolic disorders, including diabetes, dyslipidaemia and metabolic syndrome. Moreover …

Considerations for Systemic Treatment of Psoriasis in Obese Patients

P Gisondi, M Del Giglio… - American journal of …, 2016 - pubmed.ncbi.nlm.nih.gov
Psoriasis is an immune-mediated inflammatory skin disease frequently associated with
metabolic disorders, including diabetes, dyslipidaemia and metabolic syndrome. Moreover …